Showing results (861-870 of 1,025) with videos related to
Sort By:
Pageof 103
Cancer|January 9, 2003
Response to preoperative chemoradiation increases the use of sphincter-preserving surgery in patients with locally advanced low rectal carcinomaChristopher H Crane, John M Skibber, Barry W Feig, et al.American Journal of Clinical Oncology|March 31, 2016
Oncologic and Functional Hazards of Obesity Among Patients With Locally Advanced Rectal Cancer Following Neoadjuvant Chemoradiation TherapyIn J Park, Y Nancy You, John M Skibber, et al.Journal of the National Comprehensive Cancer Network : JNCCN|January 8, 2025
Physical Activity and Dexamethasone for Cancer-Related Fatigue: A Preliminary Placebo-Controlled, Randomized, Double-Blind TrialSriram Yennurajalingam, Vicente Valero, Brandon G Smalgo, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2012
PIK3CA/PTEN mutations and Akt activation as markers of sensitivity to allosteric mTOR inhibitorsFunda Meric-Bernstam, Argun Akcakanat, Huiqin Chen, et al.Annals of Surgical Oncology|October 30, 2014
Neoadjuvant therapy is associated with a reduced lymph node ratio in patients with potentially resectable pancreatic cancerChristina L Roland, Anthony D Yang, Matthew H G Katz, et al.Journal of Medical Economics|March 17, 2023
Health utilities and quality-adjusted life years for patients with amyotrophic lateral sclerosis receiving reldesemtiv or placebo in FORTITUDE-ALSPaulos Gebrehiwet, Lisa Meng, Stacy A Rudnicki, et al.Journal of the American College of Cardiology|September 19, 2003
Termination of paroxysmal supraventricular tachycardia by tecadenoson (CVT-510), a novel A1-adenosine receptor agonistEric N Prystowsky, Imran Niazi, Anne B Curtis, et al.Annals of Surgical Oncology|September 10, 2015
The Addition of Postoperative Chemotherapy is Associated with Improved Survival in Patients with Pancreatic Cancer Treated with Preoperative TherapyChristina L Roland, Matthew H G Katz, Ching-Wei D Tzeng, et al.Lancet (London, England)|August 23, 2011
Dose-dependent augmentation of cardiac systolic function with the selective cardiac myosin activator, omecamtiv mecarbil: a first-in-man studyJohn R Teerlink, Cyril P Clarke, Khalil G Saikali, et al.Oral Diseases|November 26, 2015
World Workshop on Oral Medicine VI: a systematic review of medication-induced salivary gland dysfunctionA Villa, A Wolff, N Narayana, et al.Pageof 103